Stockreport

Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run [Yahoo! Finance]

NASCENT BIOTECH INC  (NBIO) 
NASDAQ:AMEX Investor Relations: nascentbiotech.com/investor-relations
PDF clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturing run to ensu [Read more]